Abstract
Tobacco use disorder (TUD), the leading cause of preventable deaths in the United States, disproportionally impacts those with psychiatric disorders. There are multiple first-line, U.S. Food and Drug Administration–approved pharmacotherapy options for the treatment of TUD. The current review focuses on these medications, underlining practical tips to improve cessation rates, while emphasizing a harm reduction and patient-centered approach to treatment. [
Journal of Psychosocial Nursing and Mental Health Services, 61
(11), 6–9.]
Subject
Pshychiatric Mental Health,General Nursing
Reference26 articles.
1. Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice
2. Does reduced smoking if you can’t stop make any difference?
3. Centers for Disease Control and Prevention. (2020). Tobacco-related mortality. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/tobacco_related_mortality/index.htm#:∼:text=Cigarette%20smoking%20is%20estimated%20to%20cause%20the%20following%3A&text=More%20than%20480%2C000%20deaths%20annually,including%20deaths%20from%20secondhand%20smoke
4. Centers for Disease Control and Prevention. (2022). Smoking cessation: Fast facts. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/cessation/smoking-cessation-fast-facts/index.html
5. Smoking, nicotine and neuropsychiatric disorders
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Harm Reduction in Psychiatric Settings;Journal of Psychosocial Nursing and Mental Health Services;2024-07